MedPath

Detection of early premalignant breast lesions by autofluorescence ductoscopy

Phase 2
Completed
Conditions
10006291
breast carcinoma
breast cancer
Registration Number
NL-OMON40131
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

- Women >=18 age
- Indication for mastectomy by recently pathologically proven malignancy OR choosing preventive mastectomy because of highly increased risk of breast cancer development.

Exclusion Criteria

- Pregnant women
- Under 18 years of age
- Former radiotherapy of thorax or breast (on the site of the operated breast)
- Former surgery of the nipple or areola (on the site of the operated breast)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>With this study the (technical) feasibility of autofluorescence ductoscopy will<br /><br>be studied. The number and characteristics of intraductal lesions found with<br /><br>the two different types of ductoscopy (white-light vs. autofluorescence) will<br /><br>be compared. The number and visual characteristics of lesions found (and<br /><br>marked) by ductoscopy will be compared to the number and characteristics of<br /><br>lesions found by pathological analysis of the mastectomy specimens. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To investigate the correlation between the projected characteristics of a<br /><br>precursor lesion in white and autofluorescent light and its histological<br /><br>characteristics.<br /><br>*</p><br>
© Copyright 2025. All Rights Reserved by MedPath